Document:

EXECUTION
      VERSION

     

    CHINA
      MOBILE MEDIA TECHNOLOGY INC.

     

    JANUARY
      11, 2008

     

    To: The
      investor listed on Schedule
      A (the
      “Investor”)

     

    Re: Information
      and Inspection Rights Ladies and Gentlemen:

     

    This
      letter will confirm our agreement that pursuant to and effective as of your
      purchase of certain Guaranteed Senior Notes due 2014 (the “Notes”)
      to
      be
      issued by Magical Insight Investments Limited (“Magical
      Insight”),
      a
      British
      Virgin Islands corporation, and warrants (the “Warrants”, with
      the
      Warrants and the Notes collectively referred to as the “Securities”)
      issued
      by
      China Mobile Media Technology Inc. (the “Company”)
      pursuant
      to the applicable securities purchase agreement (the “Securities
      Purchase Agreement”)
      dated
      December 28, 2007 among the Company, the Investor and the other parties thereto,
      the Investor (and its successors and assigns) shall be entitled to the following
      contractual rights to certain financial information, inspection rights, and
      other rights specifically provided herein:

     

    1. Subject
      to the Company’s compliance with applicable laws and regulations and
except
      for information already provided to the Trustee pursuant to the Indenture,
      the
      Company will concurrently furnish to the Investor all material information
      (at
      the address set forth on Schedule
      A hereto
      or
      at such other address as the Investor may notify the Company in writing)
provided
      generally to all shareholders (including but not limited to financial
      statements, details of
      material contracts, and acquisitions or disposals of material assets and public
      filings with the trading market on which any of the Company’s capital stock is
      traded and the relevant regulatory authorities); provided,
      however, that
      any
      such information filed on the Securities and Exchange Commission’s EDGAR
      database need not be separately furnished.

     

    2. The
      Company will use its commercially reasonable efforts to provide the Investor
      with
      access to the books and records of the Company at all such reasonable times
      and
      as often as may be reasonably requested upon reasonable notice, provided
      that
      any
      visit by the Investor shall not unduly interrupt the daily operation of the
      Company and shall not be more frequent than quarterly if no event of default
      has
      occurred and is continuing under the indenture for the Notes, provided
      further that
      access to communications between the Company and its subsidiaries with
its
      attorneys need not be provided.

     

    Information,
      financial statements and other documents provided to the Investor or
developed
      pursuant to numbered paragraphs 1 and 2 above shall constitute “Confidential
      Information”
      for
      the
      purposes of this Agreement. The Investor agrees that it will keep confidential
      and will not disclose, divulge, or use for any purpose (other than to monitor
      its investment in the Company) any Confidential Information obtained from the
      Company pursuant to the terms of this letter, unless such Confidential
      Information (a) is known or becomes known to the public in general (other than
      as a result of a breach of this Agreement by such Investor), (b)
      is or
      has been independently developed or conceived by the Investor without use of
      the
      Company’s Confidential Information, or (c) is or has been made known or
      disclosed to the Investor by a third party without a breach of any obligation
      of
      confidentiality such third party may have to the Company; provided,
      however, that
      the
      Investor may disclose Confidential Information (i) to its attorneys,
      accountants, consultants, and other professionals to the extent necessary to
      obtain their services in connection with monitoring its investment in the
      Company; (ii) to any bona fide prospective purchaser of any securities from
      the
      Investor, if such prospective purchaser agrees to be bound by the provisions
      of
      this letter; and (iii) to any affiliate, partner, member, stockholder, or wholly
      owned subsidiary of the Investor in the ordinary course of
      business.

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    The
      rights described herein shall terminate and be of no further force or effect
      at
      such time as the Investor (together with its affiliates) holds neither (a)
      a
      principal amount of the Notes of at least RMB150,000,000, nor (b) an amount
      of
      the Company’s common stock, par value $.001, constituting at least 3.5% of the
      Company’s issued and outstanding common stock on a fully diluted basis. The
      confidentiality obligations referenced herein will survive any such
      termination.

     

    Any
      dispute, controversy or claim arising out of or in connection with this
      Agreement shall be settled through negotiation between the parties; if the
      parties fail to resolve such dispute within sixty (60) days after the date
      such
      negotiation was first requested in writing by either party, it shall be settled
      by arbitration at the Hong Kong International Arbitration Center (the
“HKIAC”)
      under
      the
      UNCITRAL Arbitration Rule. In the case of any conflict between the terms of
      this
      Agreement and the International Chamber of Commerce International Arbitration
      Rules (“ICC
      Rules”),
      the
      terms
      of this Agreement shall prevail. The arbitral tribunal shall consist of three
      arbitrators, with one appointed by the Executive, one appointed by the
      Purchasers and a third neutral arbitrator to be appointed by the other two
      party-appointed arbitrators, who shall not be a citizen of the PRC and who
      shall
      act as the chairman of the tribunal. The parties agree to the appointment of
      arbitrators who are not on HKIAC’s Panel of Arbitrators. If either party fails
      to appoint an arbitrator within the time specified in the ICC Rules or if the
      two party-appointed arbitrators fail to jointly appoint the third neutral
      arbitrator within the time specified in the ICC Rules, the Chairman of HKIAC
      shall make such an appointment. The arbitration shall be conducted on a
      confidential basis. All arbitration proceedings
      shall be held in English. Any arbitration award made by the arbitration panel
      shall be
      final
      and binding on the parties and may be entered and enforced in any court of
      competent jurisdiction. The parties shall submit to the jurisdiction of any
      such
      court for purposes of the enforcement of any such award. Notwithstanding the
      foregoing agreement to arbitrate, the parties expressly reserve the right to
      seek provisional relief from any court of competent jurisdiction to preserve
      their respective rights pending arbitration.

     

    [signature
      page follows]

     

    
      
         

      

      
        2

        
          

        

      

      
         

      

    

     

    IN
      WITNESS WHEREOF, the parties have executed this Agreement as of the date first
      written above.

     

    
      	 	 	 
	 	CHINA
              MOBILE MEDIA
              TECHNOLOGY INC.
	 
 	 
 	 
 
	
            	By:  	
            
	 	 	
              

            
	 	
              Name:

            	 
	 	Title:	 
	 	
            

    

     

    [SIGNATURE
      PAGE TO INFORMATION RIGHTS AND INSPECTION AGREEMENT]

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    
      	 	 	 
	 	ABAX
              LOTUS LTC.
	 
 	 
 	 
 
	
            	By:  	
            
	 	 	
              

            
	 	Name:	 
	 	Title:	 
	 	
            

    

     

    
      
        
           

        

        
           

          
            

          

        

        
           

        

      

       
SCHEDULE
      A

     

    NAME
      AND ADDRESS OF THE INVESTOR

     

    Abax
      Lotus Ltd.

    c/o
      Abax
      Global Capital (Hong Kong) Limited

    Suite
      6708, 67/F Two International Finance Centre

    8
      Finance
      Street

    Central,
      Hong Kong SAR

     

    Attn:
      Chairman of the Board 

    Fax:
      +852
      36021702

     

    

      [SIGNATURE
        PAGE TO INFORMATION RIGHTS AND INSPECTION AGREEMENT]EMPLOYMENT
      AGREEMENT

     

    THIS
      AGREEMENT is dated January 21, 2008 (the “Effective
      Date”)
      by and
      between FineTech, Inc, a wholly owned subsidiary of RxElite, Inc. (the
“Company”)
      and
      Rick Schindewolf (“Executive”).

     

    In
      consideration of the mutual covenants contained herein, and for such other
      good
      and valuable consideration, the receipt and sufficiency of which are hereby
      acknowledged, the parties, intending to be legally bound, agree as
      follows:

     

    1.  Employment
      and Duties.
      The
      Company hereby agrees to employ Executive as its Senior Vice President of New
      Business Development hereby accepts such employment, on the terms and conditions
      hereinafter set forth. During the Employment Period (as defined below),
      Executive shall serve in the foregoing capacities and shall report to the Chief
      Operating Officer of the Company. Executive shall have those powers and duties
      customarily associated with the foregoing positions of entities comparable
      to
      the Company and such other powers and duties as may be prescribed by the
      Board.

     

    2.  Term.
      The
      term of this Agreement (the “Term”)
      shall
      commence on the Effective Date and run for a term of five (5) years. This Term
      may be extended by the mutual agreement of both parties unless Executive’s
      employment is terminated as provided in Section 6 (the “Employment
      Period”).

     

    3.  Extent
      of Services.
      During
      the Term and any extension thereof, Executive shall devote his full time and
      efforts to the performance, to the best of his abilities, of such duties and
      responsibilities, as described in Section 1 above, and as the Board shall
      determine, consistent therewith.

     

    4.  Compensation.

     

    (a)  Salary.
      Executive shall be paid One Hundred Eighty Five Thousand Dollars (185,000)
      on an
      annualized basis (the “Base
      Salary”)
      in
      accordance with the Company’s normal payroll practices, and subject to all
      lawfully required withholding. The base salary may be increased annually as
      determined by the Board in its sole discretion.

     

    (b)  Bonus.
      Executive will be paid during 2008 5% for each $1 in EBITDA created in division
      above the current FineTech baseline EBITDA This will include all EBITDA created
      on existing contracts for products or services above the current contract and
      any new business. Executive is eligible for additional bonuses to include 3%
      on
      any EBITDA created on new product deals or other transactions brought before
      the
      company by the Executive. Deals under discussion prior to the effective date
      of
      the Executive’s contract that were being negotiated with the Executive’s prior
      employer will be eligible for 1.5% on EBITDA and any deals in negotiation that
      were not related to the Executive will be exempt from bonus.

     

    (i)  Bonus
      Carve-out A: DuoNeb and / Or Levalbuterol cooperation agreement with Cobalt
      or
      other related entity will provide 5% of EBITDA if the LOI is signed in Q1,
      2008
      and the final agreement is signed by Q2, 2008. If these conditions do not exist
      then the EBITDA target will be 3%.

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    (c)  Stock
      Options.
      Executive shall be granted 250,000 common stock options with a strike price
      of
      the 30 day prevailing price on a trailing average at the time of execution
      of
      this agreement, vesting 25% per year over 4 years.

     

    (d)  Relocation
      Costs: Executive will be compensated for documented relocation costs under
      the
      following schedule:

     

    	(1)     	
            Up
              to Fifteen Thousand Dollars ($15,000) in documented moving
              expenses

          

    	(2)    	
            Up
              to Twenty Three Thousand Dollars ($23,000) in documented closing
              costs

          

    	(3)    	
            Up
              to Three Thousand Five Hundred Dollars ($3,500) in temporary housing
              costs

          

    	(4)    	
            Up
              to Four Thousand Dollars ($4,000) in flights and transportation
              costs

          

    	(5)    	
            Expenses
              over the above limits will require pre-approval by
              RxElite.

          

     

    (e)  Executive
      Participation in the Company’s Staff Benefits Plans.
      

     

    (i)  The
      Company shall pay for Executive’s and his family’s medical insurance, as may be
      established from time to time by the Company with such carriers and such
      coverage and such terms and conditions as the Company may select. On or after
      the date hereof, the Company shall be entitled to cause Executive to participate
      in the cost of the foregoing medical insurance in such pro-rations as the
      Company may decide in its sole and absolute discretion. 

     

    (f)  Expenses.
      Executive shall be reimbursed by the Company for all ordinary, reasonable,
      customary and necessary expenses incurred by him in the performance of his
      duties and responsibilities. Executive agrees to prepare documentation for
      such
      expenses as may be necessary for the Company to comply with the applicable
      rules
      and regulations of the Internal Revenue Service.

     

    (g)  Equity
      Awards.
      Executive shall be eligible for grants of stock options, restricted stock and
      other permissible awards under the RxElite Holdings Inc. 2008 Incentive Stock
      Plan, as the Board or Compensation Committee of the Company shall, in its
      absolute and sole discretion, determine.

     

    5.  Vacation.
      Executive shall be entitled to 15 business days paid vacation and 5 paid sick
      days (which may be taken as personal days if Executive has not previously taken
      said days as sick days), per annum during Executive’s employment under this
      Agreement consistent with the Company’s vacation policy for employees generally,
provided,
      however,
      that
      Executive shall not be permitted to take more than ten consecutive business
      days
      of vacation at any particular time without the prior approval of the Company’s
      Compensation Committee. The Company’s Compensation Committee may (but shall not
      be obligated to) grant Executive such additional paid sick days, as the
      Compensation Committee may decide on a case by case basis. 

     

    6.  Termination.
      Executive’s employment by the Company shall terminate under the following
      circumstances:

     

    (a)  Death.
      If
      Executive dies, Executive’s employment shall be terminated effective as of the
      end of the calendar month during which Executive died.

     

    
      
         

      

      
        2

        
          

        

      

      
         

      

    

    (b)  Disability.
      In the
      event Executive, by reason of physical or mental incapacity, shall be
      substantially unable to perform his duties hereunder for a period of three
      (3)
      consecutive months, or for a cumulative period of six (6) months within any
      twelve (12) month period (such incapacity deemed to be “Disability”),
      the
      Company shall have an option, at any time thereafter, to terminate Executive’s
      employment hereunder as a result of such Disability. Such termination will
      be
      effective ten (10) days after the Board gives written notice of such termination
      to Executive, unless Executive shall have returned to the full performance
      of
      his duties prior to the effective date of the notice. Upon such termination,
      Executive shall be entitled to any benefits as to which he and his dependents
      are entitled by law, and except as otherwise expressly provided herein, all
      obligations of the Company hereunder shall cease upon the effectiveness of
      such
      termination other than payment of salary earned through the date of Disability,
      provided that such termination shall not affect or impair any rights Executive
      may have under any policy of long term disability insurance or benefits then
      maintained on his behalf by the Company. Executive’s Base Salary shall continue
      to be paid during any period of incapacity prior to and including the date
      on
      which Executive’s employment is terminated for Disability.

     

    (c)  Cause.
      The
      Company shall have the right to terminate Executive's employment for “Cause.”
For purposes of this Agreement, “Cause”
shall
      mean: 

     

    (i)  the
      willful or continued failure by Executive to substantially perform his duties,
      including, but not limited to, acts of fraud, willful misconduct, gross
      negligence or other act of dishonesty;

     

    (ii)  a
      material violation or material breach of this Agreement which is not cured
      within 30 days written notice to Executive;

     

    (iii)  misappropriation
      of funds, properties or assets of the Company by Executive or any action which
      has a materially adverse effect on the Company or its business; 

     

    (iv)  the
      conviction of, or plea of guilty or no contest to, a felony or any other crime
      involving moral turpitude, fraud, theft, embezzlement or dishonesty; or

     

    (v)  abuse
      of
      drugs or alcohol that impairs Executive’s ability to perform his duties as
      described in Section 1 above. 

     

    (d)  Without
      Cause.
      The
      Company shall have the right to terminate Executive’s employment hereunder
      without cause at any time by providing Executive with written notice of such
      termination, which termination shall take effect 10 days after the date such
      notice is provided. 

     

    (e)  Voluntary
      Resignation.
      Executive shall have the right to terminate his employment hereunder by
      providing the Company with a written notice of resignation. Such notice must
      be
      provided 60 days prior to the date upon which Executive wishes such resignation
      to be effective. Upon receipt of such resignation, the Company shall have the
      option to accelerate the resignation to a date prior to the expiration of the
      60
      day period.

     

    
      
         

      

      
        3

        
          

        

      

      
         

      

    

    7.  Payments
      Due Upon Termination.
      In the
      event Executive’s employment is terminated pursuant to Section 6(d) above, in
      years one through three of the agreement, then (i) any unvested stock options
      held by Executive shall immediately vest, (ii) the Company shall continue pay
      to
      Executive his base salary as in effect on the date of termination for a period
      of twelve (12) months and (iii) the Company shall reimburse Executive for
      the costs of obtaining comparable medical benefits for twelve (12) months,
      unless Executive obtains other employment that provides for comparable medical
      benefits as Executive received while employed by the Company. In the event
      Executive’s employment is terminated pursuant to Section 6(d) above, in years
      four and subsequent years of the agreement, then (i) any unvested stock options
      held by Executive shall immediately vest, (ii) the Company shall continue pay
      to
      Executive his base salary as in effect on the date of termination for a period
      of six (6) months and (iii) the Company shall reimburse Executive for the
      costs of obtaining comparable medical benefits for six (6) months, unless
      Executive obtains other employment that provides for comparable medical benefits
      as Executive received while employed by the Company. In the event Executive’s
      employment is terminated for any other reason, then Executive shall be entitled
      to receive his Base Salary through the effective date of termination and the
      Company shall reimburse Executive for any reasonable expenses previously
      incurred for which Executive had not been reimbursed prior to the termination
      of
      employment. Executive acknowledges and agrees that prior to receiving any
      payments under this Section, and as a material condition thereof, Executive
      shall, if requested by the Company, sign and agree to be bound by a general
      release of claims against the Company related to Executive’s employment (and
      termination of employment) with the Company in such form as the Company may
      deem
      appropriate. Upon Executive’s termination of employment for any reason, upon the
      request of the Board, he shall resign any memberships or positions that he
      then
      holds with the Company.

     

    8.  Vesting
      of Options upon Change of Control.
      Upon
      the occurrence of a Change of Control, unless otherwise specifically prohibited
      under the applicable laws, or the rules and regulations of any governing
      governmental agency or national securities exchange, any and all stock options
      granted by the Company to Executive shall become immediately exercisable, and
      shall remain exercisable throughout their entire term. “Change of Control” of
      the Company shall mean:

     

    (a) Acquisition
      of Shares.
      The
      acquisition by any individual, entity or group (within the meaning of Section
      13(d)(3) of the Securities Exchange Act of 1934, amended (the “Exchange Act”))
      (a “Person”) of beneficial ownership (within the meaning of Rule 13d-3
      promulgated under the Exchange Act) of 20% or more of either (a) the outstanding
      shares of common stock of the Company (the “Outstanding Company Common Stock”)
      or (b) the combined voting power of the then outstanding voting securities
      of
      the Company entitled to vote generally in the election of directors (the
“Outstanding Company Voting Securities”); provided, however, that for purposes
      of this subsection (a), the following acquisitions shall not constitute a Change
      of Control: (i) any acquisition by the Company, (ii) any acquisition by any
      employee benefit plan (or related trust) sponsored or maintained by the Company
      or any corporation controlled by the Company or (iii) any acquisition by any
      corporation pursuant to a transaction which complies with clauses (i), (ii)
      and
      (iii) of subsection (c) below; or

    

    (b) Change
      in Board.
      Individuals who, as of the date hereof, constitute the Board (the “Incumbent
      Board”) cease for any reason to constitute at least majority of the Board;
      provided, however, that any individual becoming a director subsequent to the
      date hereof whose election, or nomination for election by the Company’s
      shareholders, was approved by a vote of at least a majority of the directors
      then comprising the Incumbent Board shall be considered as though such
      individuals were a member of the Incumbent Board, but excluding, for this
      purpose, any such individual whose initial assumption of office occurs as a
      result of an actual or threatened election contest with respect to the election
      or removal of directors or other actual or threatened solicitation of proxies
      or
      consents by or on behalf of a Person other than the Board; or 

    

    
      
         

      

      
        4

        
          

        

      

      
         

      

    

    (c) Business
      Combination.
      Consummation of a reorganization, merger or consolidation or sale or other
      disposition of all or substantially all of the assets of the Company (a
“Business Combination”), in each case, unless, following such Business
      Combination, (i) all or substantially all of the individuals and entities who
      were the beneficial owners, respectively, of the Outstanding Company Common
      Stock and Outstanding Company Voting Securities immediately prior to such
      Business Combination beneficially own, directly or indirectly, more than 50%
      of,
      respectively, the then outstanding shares of common stock and the combined
      voting power of the then outstanding voting securities entitled to vote
      generally in the election of directors, as the case may be, of the corporation
      resulting from such Business Combination (including, without limitation, a
      corporation which as a result of such transaction owns the Company or all or
      substantially all of the Company’s assets either directly or through one or more
      subsidiaries) in substantially the same proportions as their ownership,
      immediately prior to such Business Combination of the Outstanding Company Common
      Stock and Outstanding Company Voting Securities, as the case may be, (ii) no
      Person (excluding any employee benefit plan (or related trust) of the Company
      or
      such corporation resulting from such Business Combination) beneficially owns,
      directly or indirectly, 20% or more of, respectively, the then Outstanding
      Company Common Stock or the combined voting power of the then Outstanding Voting
      Securities of such corporation except to the extent that such ownership existed
      prior to the Business Combination and (iii) at least a majority of the members
      of the board of directors of the corporation resulting from such Business
      Combination were members of the Incumbent Board at the time of the execution
      of
      the initial agreement, or of the action of the Board, providing for such
      Business Combination; or 

    

    (d)  Approval
      by the shareholders of the Company of a complete liquidation or dissolution
      of
      the Company.

    

    9.  Surrender
      of Books and Papers.
      Upon
      termination of this Agreement (irrespective of the time, manner, or cause of
      termination, be it for cause or otherwise), Executive shall immediately
      surrender to the Company all books, records, or other written papers or
      documents entrusted to him or which he has otherwise acquired pertaining to
      the
      Company and all other Company property in Executive’s possession, custody or
      control.

     

    10.  Inventions
      and Patents.
      Executive agrees that Executive will promptly from time-to-time fully inform
      and
      disclose to the Company any and all ideas, concepts, copyrights, copyrightable
      material, developments, inventions, designs, improvements and discoveries of
      whatever nature that Executive may have or produce during the term of
      Executive’s employment under this Agreement that pertain or relate to the then
      current business of the Company (the “Creations”),
      whether conceived by Executive alone or with others and whether or not conceived
      during regular working hours. All Creations shall be the exclusive property
      of
      the Company and shall be “works made for hire” as defined in 17 U.S.C. §101, and
      the Company shall own all rights in and to the Creations throughout the world,
      without payment of royalty or other consideration to Executive or anyone
      claiming through Executive. Executive hereby transfers and assigns to the
      Company (or its designee) all right, title and interest in and to every
      Creation. Executive shall assist the Company in obtaining patents or copyrights
      on all such inventions, designs, improvements and discoveries being patentable
      or copyrightable by Executive or the Company and shall execute all documents
      and
      do all things necessary to obtain letters of patent or copyright, vest the
      Company with full and exclusive title thereto, and protect the same against
      infringement by others, and such assistance shall be given by Executive, if
      needed, after termination of this Agreement for whatever cause or reason.
      Executive hereby represents and warrants that Executive has no current or future
      obligation with respect to the assignment or disclosure of any or all
      developments, inventions, designs, improvements and discoveries of whatever
      nature to any previous employer, entity or other person and that Executive
      does
      not claim any rights or interest in or to any previous unpatented or
      uncopyrighted developments, inventions, designs, improvements or
      discoveries.

     

    
      
         

      

      
        5

        
          

        

      

      
         

      

    

    11.  Trade
      Secrets, Non-Competition and Non-Solicitation.

     

    (a)  Trade
      Secrets.
      Contemporaneous with the execution of this Agreement and during the term of
      employment under this Agreement, the Company shall deliver to Executive or
      permit Executive to have access to and become familiar with various confidential
      information and trade secrets of the Company, including, without limitation,
      data, production methods, customer lists, product format or developments, other
      information concerning the business of the Company and other unique processes,
      procedures, services and products of the Company, which are regularly used
      in
      the operation of the business of the Company (the “Confidential
      Information”).
      Executive shall not disclose any of the Confidential Information that he
      receives from the Company, or its clients and customers in the course of his
      employment with the Company, directly or indirectly, nor use it in any way,
      either during the term of this Agreement or at any time thereafter, except
      as
      required in the course of employment with the Company. Executive further
      acknowledges and agrees that Executive owes the Company a fiduciary duty to
      preserve and protect all Confidential Information from unauthorized disclosure
      or unauthorized use. All files, records, documents, drawings, graphics,
      processes, specifications, equipment and similar items relating to the business
      of the Company, whether prepared by Executive or otherwise coming into
      Executive’s possession in the course of his employment with the Company, shall
      remain the exclusive property of the Company and shall not be removed from
      the
      premises of the Company without the prior written consent of the Company unless
      removed in relation to the performance of Executive’s duties under this
      Agreement. Any such files, records, documents, drawings, graphics,
      specifications, equipment and similar items, and any and all copies of such
      materials that have been removed from the premises of the Company, shall be
      returned by Executive to the Company. Executive further acknowledges that the
      covenants of Executive herein are intended to include the protection of the
      confidential information of each of the Company’s customers and clients, that
      come into the possession of Executive as a result of his employment with the
      Company, and that such customers and clients of the Company shall be entitled
      to
      rely on and enforce these covenants against Executive for their own
      benefit.

     

    (b)  Non-Competition.
      Executive acknowledges that (i) he will be provided with and have access to
      the
      Confidential Information, the unauthorized use or disclosure of which would
      cause irreparable injury to the Company, (ii) the Company’s willingness to enter
      into this Agreement is based in material part on Executive’s agreement to the
      provisions of this Section 10(b)
      and
      (iii) Executive’s breach of the provisions of this Section would materially and
      irreparably damage the Company. In consideration for the Company’s disclosure of
      Confidential Information to Executive, Executive’s access to the Confidential
      Information, and the salary paid to Executive by the Company hereunder,
      Executive agrees that during the Term and for one (1) year thereafter,
      regardless of whether such termination is with or without Cause, Executive
      shall
      not, directly or indirectly, either as an executive, employee, employer,
      consultant, agent, principal, partner, stockholder, corporate officer, director,
      advisor or in any other individual or representative capacity, engage or
      participate in any business that is in competition in any manner whatsoever
      with
      any business conducted by the Company at any time prior to, or during,
      Executive’s employment hereunder.

     

    
      
         

      

      
        6

        
          

        

      

      
         

      

    

    (c)  Reasonableness
      of Restrictions.
      Executive acknowledges that the restrictions set forth in Section
      10(b)
      of this
      Agreement are reasonable in scope and necessary for the protection of the
      business and goodwill of the Company. Executive agrees that should any portion
      of the covenants in Section
      10
      be
      unenforceable because of the scope thereof or the period covered thereby or
      otherwise, the covenant shall be deemed to be reduced and limited to enable
      it
      to be enforced to the maximum extent permissible under the laws and public
      policies applied in the jurisdiction in which enforcement is
      sought.

     

    (d)  Soliciting
      Employees.
      Executive shall not during the Term or for a period of one (1) year thereafter
      for any reason, whether by resignation, discharge or otherwise, either directly
      or indirectly, employ, enter into agreement with, or solicit the employment
      of,
      any employee of the Company for the purpose of causing them to leave the
      employment of the Company or take employment with any business that is in
      competition in any manner whatsoever with the business of the
      Company.

     

    (e)  Injunctive
      Relief; Extension of Restrictive Period.
      In the
      event of a breach of any of the covenants by Executive or the Company contained
      in this Agreement, it is understood that damages will be difficult to ascertain,
      and either party may petition a court of law or equity for injunctive relief
      in
      addition to any other relief which Executive or the Company may have under
      the
      law, including, but not limited to, reasonable attorneys’ fees.

     

    12.  Miscellaneous.

     

    (a)  Assignment.
      This
      Agreement shall be binding upon the parties and their respective heirs,
      executors, administrators, successors and assigns. Executive shall not assign
      any part of his rights under this Agreement without the prior written consent
      of
      the Company.

     

    (b)  Entire
      Agreement.
      This
      Agreement contains the entire agreement and understanding between the parties
      and supersedes any and all prior understandings and agreements between the
      parties regarding Executive’s employment.

     

    (c)  Modification;
      Waiver.
      No
      modification hereof shall be binding unless made in writing and signed by the
      party against whom enforcement is sought. No waiver of any provisions of this
      Agreement shall be valid unless the same is in writing and signed by the party
      against whom it is sought to be enforced, unless it can be shown through custom,
      usage or course of action.

     

    (d)  Governing
      Law.
      This
      Agreement is executed in, and it is the intention of the parties hereto that
      it
      shall be governed by, the laws of the State of Delaware without giving effect
      to
      applicable conflict of laws provisions.

     

    (e)  Severability.
      The
      provisions of this Agreement shall be deemed to be severable, and the invalidity
      or unenforceability of any provision shall not affect the validity or
      enforceability of the other provisions hereof.

     

    
      
         

      

      
        7

        
          

        

      

      
         

      

    

    (f)  Notices.
      Any
      notice or communication permitted or required by this Agreement shall be in
      writing and shall become effective upon personal service, or service by wire
      transmission, which has been acknowledged by the other party as being received,
      or two (2) days after its mailing by certified mail, return receipt requested,
      postage prepaid addressed as follows:

     

    
      	
            	(i)	
              If
                to the Company:

            

      	 	 	 

      	 	 	
              RxElite
                Holdings Inc.

            

      	 	 	
              1404
                N. Main Street, 

            

      	 	 	
              Suite
                200

            

      	 	 	
              Meridian,
                ID 83642

            

      	 	 	
              Attn:
                Chief Operating Officer

            

      	 	 	 

      	 	(ii)	
              If
                to Executive, to: 

            

      	 	 	 

      	 	 	
              Rick
                Schindewolf

            

      	 	 	
              6507
                Burning Tree Circle

            

      	 	 	
              McHenry,
                IL 60050

            

    

              
      

    (g)  Non-Disparagement.
      Both
      parties acknowledge and agree not to defame or publicly criticize the services,
      business, integrity, veracity or personal or professional reputation of the
      other, in either a professional or personal manner, at any time during or
      following the employment period. With respect to the Company, this shall include
      any officers, directors, partners, executives, employees, representatives or
      agents of the Company.

     

    (h)  Counterparts.
      This
      Agreement may be executed in one or more counterparts, each of which shall
      be
      deemed as original but all of which together shall constitute one and the same
      instrument.

     

     

    IN
      WITNESS WHEREOF,
      the
      Company and Executive have executed this Agreement as of the Effective
      Date.

     

    
      
        	
                RXELITE
                  HOLDINGS INC.

              	
              	
                EXECUTIVE

              
	 	 	 
	 	 	 
	
                By:
                  /s/ Earl E. Sullivan                           

              	
              	
                /s/ Rick
                  Schindewolf                           

              
	
                Name:
                  Earl
                  E. Sullivan

              	
              	
                Rick
                  Schindewolf

              
	
                Title:  
                  Chief
                  Operating Officer

              	
              	 

      

    

     

    
      
         

      

      
        8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00135-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00135-of-00352.parquet"}]]